Ads
related to: tirzepatide weight lossro.co has been visited by 100K+ users in the past month
Search results
Results from the Tech24 Deals Content Network
Treatment with tirzepatide, the chemical name for Lilly's obesity drug Zepbound and diabetes treatment Mounjaro, resulted in an average weight reduction of 22.9%, compared to just 2.1% for the ...
In the 72-week SURMOUNT-1 trial, tirzepatide was tested for weight loss in people with obesity, with the following results. Depending on the dose, participants using tirzepatide lost between 15% ...
A new class of medications, called GLP-1s, including tirzepatide, which Lilly sells as Zepbound for weight loss, is the first effective treatment for many people.
Tirzepatide is an antidiabetic medication used for the treatment of type 2 diabetes [ 9][ 12][ 13][ 14] and for weight loss. [ 10][ 15] Tirzepatide is administered via subcutaneous injections (under the skin). [ 9][ 12] It is sold under the brand names Mounjaro for diabetes treatment, [ 9] and Zepbound for weight loss. [ 10]
Overall, the study found that tirzepatide was more effective at helping participants lose weight. About 82% of participants taking tirzepatide experienced 5% or greater weight loss. In comparison ...
For the efficacy estimand, tirzepatide led to a 15.7% (in a combined population of people with and without type 2 diabetes) body weight reduction compared to 2.2% for placebo.
Ads
related to: tirzepatide weight lossro.co has been visited by 100K+ users in the past month